RIGEL PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9504 USD | -3.27% |
|
-3.45% | -34.46% |
| May. 07 | Transcript : Rigel Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
| May. 07 | Earnings Flash (RIGL) RIGEL PHARMACEUTICALS Posts Q1 Revenue $29.5M, vs. Street Est of $31.5M | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Bio Therapeutic Drugs | -3.27% | -3.45% | -34.46% | -47.78% | -55.80% | 172M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- RIGL Stock
- Charts Rigel Pharmaceuticals, Inc.
- Comparison Chart
